The BioMed Alliance welcomes the first review of the Directive on the protection of animals used for scientific purposes (Directive 2010/63/EU). The BioMed Alliance agrees with the European Commission that efforts now need to be more strongly directed towards ensuring the Directive’s proper implementation and enforcement in all EU Member States.

More info here

BioMed Alliance and FEAM have joined forces to highlight the need to provide a more robust environment for academic clinical and health research in Europe in view of the forthcoming EU Framework Programme for Research and Innovation (FP9).

More info here

BioMed Alliance response to the European Medicines Agency’s public consultation: Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products

The European Medicines Agency has released for public consultation a draft guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products. 

More info here

BioMed Alliance Position Statement in support of the EU Directive on Animal Research (2010/63/EU)

European researchers call for the intensification of efforts to develop and adopt alternative approaches, while ensuring a viable context for the pursuit of animal experimentation, when unavoidable.

More info here

BioMed Alliance's position on the European Innovation Council

The Alliance for Biomedical Research in Europe endorses the League of European Research Universities’ position and the Wellcome Trust’s Statement in support of the EU Directive on the protection of animals used for scientific purposes.